Variants loci and phenotype correlation of TRIM8-related neuro-renal syndrome: three cases reports and literature review

Qiu Lv, Yue Niu, Zhao Xu, Jiong Qin, Zhixian YangFrontiers in Neurology 2024 · DOI

TL;DR

This paper expands our understanding of TRIM8-related neuro-renal syndrome (NRS), a rare genetic disorder that simultaneously attacks the brain and kidneys. By reporting three new cases and synthesizing data from 24 previous reports, the authors identify a "hotspot" for mutations in exon 6 and suggest that the position of the mutation along the gene may influence whether a patient faces primarily neurological or renal challenges.

What Problem Does This Paper Address?

Neuro-renal syndrome (NRS) is a complex condition where patients suffer from both developmental/neurological issues (like epilepsy and autism) and severe kidney dysfunction (like nephrotic syndrome). The culprit is the TRIM8 gene, which encodes a protein vital for protein quality control and intracellular signaling in both neurons and kidney cells (podocytes).

Because the condition is rare, clinicians struggle with prognosis: Why do some patients progress to end-stage renal disease while others don't? Why is the epilepsy drug-resistant in some but manageable in others? This paper seeks to clarify the genotype-phenotype correlation—essentially mapping specific genetic "typos" to their clinical outcomes—to help doctors better predict and manage the disease.

Methods

The researchers employed a two-pronged approach:

  1. Clinical Case Studies: They performed trio-based Whole Exome Sequencing (WES) on three Chinese pediatric patients. This involves sequencing the DNA of the child and both parents to identify de novo (newly occurring) mutations. They also conducted standard clinical workups, including brain MRIs, EEGs, and renal biopsies.
  2. Systematic Literature Review: They scoured databases (PubMed, HGMD) for all previously reported cases of TRIM8 variants up to December 2023, bringing the total cohort for analysis to 27 patients.

Datasets

As a clinical study, the "dataset" consists of human clinical data rather than a computational benchmark.

  • New Data: 3 previously unpublished cases from Peking University People’s Hospital.
  • Aggregated Data: 24 cases from existing literature.
  • Reference Databases: Variants were compared against population databases like ExAC, gnomAD, and 1000 Genomes to ensure they were truly rare and pathogenic.

Key Insights and Ideas

  • The Exon 6 Hotspot: All 18 known pathogenic variants of TRIM8 are located in exon 6. These are "truncating" variants, meaning they cause the protein to be cut short, likely leading to mislocalization within the cell's nucleus.
  • The N-to-C Gradient: The study suggests a spatial pattern to the symptoms. Variants closer to the N-terminal (the start of the protein) tended to cause neurological disease without renal damage. Conversely, variants closer to the C-terminal (the end) were associated with milder neurological symptoms.
  • Phenotypic Plasticity: Interestingly, even patients with the exact same mutation (specifically the common Gln459* variant) showed widely different levels of severity. This suggests that other genetic modifiers or environmental factors are at play.
  • Dual-System Vulnerability: The TRIM8 protein is highly expressed in both the brain and the kidney's podocytes. The study reinforces that any child presenting with both unexplained developmental delay/epilepsy and proteinuria (protein in the urine) should be screened for TRIM8 mutations.

Key Results

  • Prevalence of Symptoms: Among the 27 patients, renal disease (89%) and developmental delay (89%) were the most common features, followed by epilepsy (78%).
  • Renal Progression: 67% of patients eventually progressed to end-stage renal disease (ESRD), highlighting the aggressive nature of the kidney component.
  • Neurological Impact: 52% of patients suffered from drug-resistant epilepsy. Focal seizures were the most frequent type (57%), and 50% of those with abnormal MRIs showed brain atrophy.
  • The "Common" Variant: The Gln459* variant accounted for 25.9% of all cases, making it a primary target for future functional research.

Limitations and Future Work

The primary limitation is the small sample size ($N=27$), which is common in rare disease research but makes statistical correlations difficult. While the authors observed a trend regarding the location of the mutation (N-terminal vs. C-terminal), the "why" remains a mystery.

The authors call for functional studies to determine exactly how these truncated proteins disrupt the nuclear bodies of cells. Understanding the molecular mechanism—specifically how TRIM8 interacts with the SOCS-1 protein to regulate inflammation—could eventually lead to targeted therapies that go beyond just managing symptoms with anti-seizure meds or blood pressure drugs.

Summary updated

Abstract

This study expands the number of individuals with confirmed NRS due to pathogenic variants in <i>TRIM8</i>. Neurological and renal phenotype with the same variant locus differed in their severity. Further research is needed to explore the relationship between genotype and phenotype of <i>TRIM8</i> variants.
BibTeX
@inproceedings{lv2024variants,
  author = {Qiu Lv and Yue Niu and Zhao Xu and Jiong Qin and Zhixian Yang},
  title = {{Variants loci and phenotype correlation of TRIM8-related neuro-renal syndrome: three cases reports and literature review}},
  booktitle = {Frontiers in Neurology},
  year = {2024},
  doi = {10.3389/fneur.2024.1410187},
}
Figure